Bellon JR, Tayob N, Yang DD, Tralins J, et al. Local therapy outcomes and toxicity from the (anonymized for review) trial: A phase II randomized trial of adjuvant trastuzumab emtansine vs. paclitaxel in combination with trastuzumab in women with stage I HER2-positive breast cancer. Int J Radiat Oncol Biol Phys 2022 Jan 3. pii: S0360-3016(21)03446.
PMID: 34990776